GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » Debt-to-Equity

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Debt-to-Equity : 1.45 (As of Mar. 2017)


View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co Debt-to-Equity?

Aoxing Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $27.62 Mil. Aoxing Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $0.10 Mil. Aoxing Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2017 was $19.11 Mil. Aoxing Pharmaceutical Co's debt to equity for the quarter that ended in Mar. 2017 was 1.45.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Aoxing Pharmaceutical Co's Debt-to-Equity or its related term are showing as below:

AOXG's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Aoxing Pharmaceutical Co Debt-to-Equity Historical Data

The historical data trend for Aoxing Pharmaceutical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co Debt-to-Equity Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 4.76 -12.90 2.83 1.33

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 1.33 1.30 1.29 1.45

Competitive Comparison of Aoxing Pharmaceutical Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Aoxing Pharmaceutical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aoxing Pharmaceutical Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aoxing Pharmaceutical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's Debt-to-Equity falls into.



Aoxing Pharmaceutical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Aoxing Pharmaceutical Co's Debt to Equity Ratio for the fiscal year that ended in Jun. 2016 is calculated as

Aoxing Pharmaceutical Co's Debt to Equity Ratio for the quarter that ended in Mar. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aoxing Pharmaceutical Co  (OTCPK:AOXG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Aoxing Pharmaceutical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.
Executives
Wilfred Chow officer: Chief Financial Officer 30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea director C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo director, officer: Secretary 80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines